The main purpose is to determine whether Triferic, administered orally with Shohl's solution,
is safe and effective for the treatment of iron-refractory iron-deficiency anemia (IRIDA).
Phase:
Phase 2
Details
Lead Sponsor:
Rockwell Medical Technologies, Inc.
Treatments:
Citric Acid Iron Pharmaceutical Solutions Sodium Citrate